With 5.02 million shares changed hands, the volume of the stock remained lighter than its average volume of 6.56 million shares. The 52-week range on GEVO shows that it touched its highest point at $3.39 and its lowest point at $0.48 during that stretch. It currently has a 1-year price target of $5.79. Beta for the stock currently stands at 2.69.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GEVO was down-trending over the past week, with a drop of -16.02%, but this was down by -21.24% over a month. Three-month performance surged to 5.56% while six-month performance rose 102.67%. The stock gained 73.91% in the past year, while it has lost -27.27% so far this year. A look at the trailing 12-month EPS for GEVO yields -0.33 with Next year EPS estimates of -0.30. For the next quarter, that number is -0.08. This implies an EPS growth rate of -32.67% for this year and 20.49% for next year. EPS is expected to decline by -7.55% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 45.44%.
Float and Shares Shorts:
At present, 239.41 million GEVO shares are outstanding with a float of 227.15 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GEVO since 2 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.37119 being high and -$0.37175 being low. For GEVO, this leads to a yearly average estimate of -$0.37147. Based on analyst estimates, the high estimate for the next quarter is -$0.06 and the low estimate is -$0.11. The average estimate for the next quarter is thus -$0.09.
